Sign in
Re: Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified: J. R. Bhatt, M. A. Jewett, P. O. Richard, S. Kawaguchi, N. Timilshina, A. Evans, S. Alibhai and A. Finelli J Urol 2016;196:1350-1355
Journal article   Peer reviewed

Re: Multilocular Cystic Renal Cell Carcinoma: Pathological T Staging Makes No Difference to Favorable Outcomes and Should be Reclassified: J. R. Bhatt, M. A. Jewett, P. O. Richard, S. Kawaguchi, N. Timilshina, A. Evans, S. Alibhai and A. Finelli J Urol 2016;196:1350-1355

Ronda J Sanders and Oleksandr N Kryvenko
The Journal of urology, Vol.197(5), pp.1358-1359
2017-05
PMID: 28167073

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.233 Pelvic & Renal Disorders
1.233.501 Renal Cell Carcinoma
Web Of Science research areas
Urology & Nephrology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details